DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0031117 | Peripheral Neuropathy | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0025958 | Microcephaly | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0002736 | Amyotrophic Lateral Sclerosis | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0003028 | Anhidrosis | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0024623 | Malignant neoplasm of stomach | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0398625 | Protein C Deficiency | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0699790 | Colon Carcinoma | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0007102 | Malignant tumor of colon | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0025202 | melanoma | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0018378 | Guillain-Barre Syndrome | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0026769 | Multiple Sclerosis | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0003125 | Anorexia Nervosa | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0006142 | Malignant neoplasm of breast | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0011854 | Diabetes Mellitus, Insulin-Dependent | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0013336 | Dwarfism | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0007097 | Carcinoma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0027651 | Neoplasms | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0699791 | Stomach Carcinoma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0037369 | Smoking | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C1306459 | Primary malignant neoplasm | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0006142 | Malignant neoplasm of breast | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0017638 | Glioma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0023467 | Leukemia, Myelocytic, Acute | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C2931822 | Nasopharyngeal carcinoma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0279626 | Squamous cell carcinoma of esophagus | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024